Skip Navigation

JNCI Journal of the National Cancer Institute 2004 96(4):260; doi:10.1093/jnci/96.4.260-a
© 2004 by Oxford University Press
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Arnold, K.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Arnold, K.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 2004 Oxford University Press

NEWS

In Brief

Katherine Arnold

The first 10% of the full text of this article appears below.

Aspirin Associated With Reduced Risk of Colorectal Adenomas

Regular aspirin use is associated with a reduced risk of colorectal adenomas, according to a new study.

The effect of regular aspirin use on cancer risk has been a subject of much study (see related news story, p. 252). For colorectal cancer, questions linger about the potential dose–response relationship of aspirin and colorectal adenomas and about whether aspirin can reduce the risk of colorectal . . . [Full Text of this Article]

Cancer Patients Do Not Necessarily Fare Better in Clinical Trials, Study Suggests

Randomization Not Well Understood in Pediatric Trials


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?